Split dosing vs dose reduction If side effects are the primary concern, reducing the dose is the simplest solution
Sprout Health Weight Loss products are not intended to diagnose, treat, cure, or prevent any disease
Clinical trial data indicates that newer multi-agonist therapies deliver superior efficacy in glycemic control and weight reduction compared to existing, established treatments
As dermatologists, we are increasingly seeing patients on these medications (or prescribing them), yet the dermatologic literature on their cutaneous adverse effects was sparse and largely limited to case reports
This includes: Increased Glucose Uptake: Enhancing the transport of glucose into cells
But the addition of glucagon receptor agonism overwhelms the GIP benefit